OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. (OPK) on March 18, 2026. The report discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Subbarao V. Uppaluri, Ph.D., as a new director with immediate effect. Dr. Uppaluri was appointed to fill a vacancy on the Board resulting from the passing of Dr. Richard Krasno, who had served since February 2017. Dr. Uppaluri is expected to be appointed to the Compensation Committee and has been determined to be independent under SEC and Nasdaq rules.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No new risks, contingencies, or unusual items were disclosed in this report. Dr. Uppaluri will participate in standard non-employee director compensation arrangements and has entered into a standard director indemnification agreement.
Key Facts for Investor Verification
- Subbarao V. Uppaluri, Ph.D., was appointed to the Board of Directors on March 18, 2026.
- The appointment fills the vacancy left by the late Dr. Richard Krasno.
- Dr. Uppaluri previously served as the Company's CFO from 2007 to 2012 and as a consultant until 2014.
- Dr. Uppaluri is expected to join the Compensation Committee.
- No financial data or operational updates are included in this filing.